@article {651009,
	title = {Hydroxychloroquine and the allure and perils of abandoning evidence-based science and policy in times of crisis. (SARS-CoV-2, Covid-19 pandemic)},
	journal = {Taking Bearings. Harvard Blogs},
	number = {Mar 22},
	year = {2020},
	abstract = {
	In a disaster, the coronavirus pandemic providing a ready example, cries to abandon caution and gamble on solutions can lead to spectacular success and deadly failures.



	President Trump continues to tout an antibiotic and anti-viral drug called hydroxychloroquine as a potential treatment for Covid-19. More than just promoting the treatment, Trump urges its use, including prophylactic use. With regard to efficacy, Trump said, "It may work, it may not." Moreover, because the drug has proven relatively safe when used under other specific circumstances (e.g., treatment of malaria, lupus, rheumatoid arthritis, and other autoimmune diseases), Trump asserts, "What is there to lose?" more



	Originally published 22 March, 2020, Updated: 10 April, 2020.



	\&nbsp;

},
	author = {K.Lee Lerner}
}
